ArticlePharmaceutics2024

Intranasal Administration of Mesenchymal Stem Cell-Derived Exosome Alleviates Hypoxic-Ischemic Brain Injury.

Takuma Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.